Print Page | Close Window

Analysts


FirmAnalystPhone
Aegis Capital Corp.Raghuram Selvaraju(212) 813-1010
Dawson James Robert Wasserman(561) 208-2905
Galectin Therapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Galectin Therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Galectin Therapeutics or its management. Galectin Therapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.